End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
189,000 KRW | +0.80% | +7.02% | -6.20% |
04-24 | Market Share of Celltrion’s Remsima Rises to 74% in Europe | MT |
04-17 | Celltrion, Inc. announces an Equity Buyback for 436,047 shares. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.20% | 28.92B | |
+20.76% | 47.9B | |
+46.79% | 41.42B | |
-2.44% | 40.7B | |
+9.82% | 25.55B | |
-20.76% | 19.27B | |
+0.31% | 12.15B | |
+30.04% | 12.14B | |
-0.42% | 11.99B | |
+17.83% | 11.64B |
- Stock Market
- Equities
- A068270 Stock
- News Celltrion, Inc.
- Britain’s MHRA Clears Celltrion's Cancer Drug Vegzelma for Marketing in the UK